Showing 22,331 results

Filters Content type: Editors' picks
Health monitoring in resource-limited settings

Issue Brief: Achieving undetectable: what questions remain in scaling-up HIV virologic treatment monitoring?

Editor's pick
MSF
15 December 2014
Harm reduction

Harm reduction programs need more flexibility to work properly in Eastern Europe

Editor's pick
Aidspan
15 December 2014
Harm reduction

Opioid substitution therapy and HIV prevention in Belarus

Editor's pick
UNAIDS
15 December 2014
Hepatitis C symptoms & diagnosis

Hepatitis C ruled out as cause of mental impairment in HIV patients

Editor's pick
Washington University press release
15 December 2014
Hepatitis C symptoms & diagnosis

Scaling up screening for viral hepatitis in Europe

Editor's pick
Medical Xpress
15 December 2014
Types of HIV tests

FDA OKs Wider Use of Rapid Test That Better Detects Early HIV

Editor's pick
AIDSMeds
12 December 2014
UK health services

Save Our Service

Editor's pick
Birmingham Heartlands HIV Service
12 December 2014
Drug-resistant TB

Johnson & Johnson announces collaboration between Janssen and USAID to expand access to anti-multidrug-resistant tuberculosis (MDR-TB) compound

Editor's pick
PR Newswire
12 December 2014
HIV prevention policy

National HIV Prevention Funding – An essential investment

Editor's pick
National AIDS Trust
12 December 2014
Government, leadership & policy

The International AIDS Society announces Amsterdam as site of the International AIDS Conference in July 2018

Editor's pick
International AIDS Society
12 December 2014
Pharmaceutical industry

Class Action Lawsuit Challenges Exorbitant Pricing of Gilead’s Hepatitis-C Drug Sovaldi

Editor's pick
Chimicles & Tikellis press release
12 December 2014
Resistance

Drug-resistant infections could lead to 10 million extra deaths a year – report

Editor's pick
The Guardian
11 December 2014
Hepatitis C treatment

Philadelphia Agency Sues Gilead Over Price Of Hepatitis Drug

Editor's pick
Nasdaq
11 December 2014
New & experimental hepatitis C treatment

Daclatasvir for hepatitis C: added benefit not proven

Editor's pick
German Institute for Quality and Efficiency in Health Care (IQWiG)
11 December 2014
HIV prevention policy

How San Francisco Is Getting to Zero On HIV

Editor's pick
Huffington Post
11 December 2014
Telling people you have HIV

Beyond 'HIV Status': Interface Design Is Personal at SCRUFF

Editor's pick
Huffington Post
11 December 2014
Human rights

Blinded by Fear: How Politics Influenced Medical Policy in Greece

Editor's pick
The Politic
10 December 2014
HIV prevention policy

Uganda: Emphasising evidence-based prevention technologies a better deal

Editor's pick
New Vision
10 December 2014
Contraception

Can Women Living with HIV and Taking Antiretroviral Therapy Use Hormonal Contraceptive Methods?

Editor's pick
K4Health
10 December 2014
Bad science & bogus treatments

Preventing bad reporting on health research

Editor's pick
BMJ
10 December 2014
PrEP

unPrEPared

Editor's pick
Alex Sparrowhawk: HIV & Me (blog)
10 December 2014
Hepatitis C treatment

Will AbbVie's 3-DA regimen prove a compelling competitor to Gilead's Harvoni?

Editor's pick
Hepatitis C New Drugs
10 December 2014
Health monitoring in resource-limited settings

Sophisticated HIV diagnostics adapted for remote areas

Editor's pick
Science Daily
10 December 2014
Sexually transmitted infections tests & treatment

New herpes treatment strategy described by researchers

Editor's pick
Science Daily
10 December 2014